Form 4: Cibus Director Mark Finn Receives Significant Stock Option Grant

Cibus, Inc. Director Mark Terrence Finn was granted 39,301 stock options with an exercise price of $2.77, aligning his interests with shareholder value.

Summary

• Mark Terrence Finn, a Director of Cibus, Inc. (CBUS), acquired 39,301 stock options on May 22, 2025.
• The stock options have an exercise price of $2.77 per share.
• These options are for Class A Common Stock, with each option representing the right to buy one share.
• The options are set to vest in full on the earlier of May 22, 2026 (the first anniversary of the grant date) or the date of the Company's next annual meeting of shareholders, subject to Mr. Finn's continued service.
• The expiration date for these options is May 22, 2035.
• Following this transaction, Mr. Finn beneficially owns 39,301 derivative securities (stock options) directly.

Sentiment

Score: 7

Explanation: The document reports a routine grant of stock options to a director, which is a standard compensation practice and aligns the director's interests with shareholder value creation. This is generally viewed as a neutral to slightly positive event as it incentivizes leadership.

Positives

• The grant of stock options to a director aligns their financial interests with the long-term performance and shareholder value creation of the company.
• This is a standard form of compensation for directors, indicating ongoing commitment and incentivization.

Negatives

• The options are not immediately exercisable and are subject to vesting conditions, meaning the director does not yet hold the underlying shares.
• The value of the options is dependent on the future stock price of Cibus, Inc. exceeding the exercise price of $2.77.

Risks

• The value of the stock options is subject to market fluctuations of Cibus, Inc.'s Class A Common Stock.
• Vesting of the options is contingent upon the director's continued service to the company.
• Potential dilution for existing shareholders if and when these options are exercised and converted into common stock.

Future Outlook

The document primarily details an insider transaction and does not provide forward-looking statements regarding the company's financial performance or strategic guidance, beyond the vesting schedule for the granted options.

Industry Context

The grant of stock options to directors is a common and widely accepted practice across various industries, particularly in publicly traded companies, as a means of executive and director compensation. It aims to incentivize long-term performance and align the interests of leadership with those of shareholders.

Comparison to Industry Standards

• Granting stock options as part of director compensation is a standard practice observed across many public companies, including those in the biotechnology and agricultural technology sectors like Cibus, Inc.
• The specific terms, such as the exercise price and vesting schedule, are typical for such grants, often tied to service periods to ensure retention and commitment.

Related Party Transactions

• The grant of stock options to Mark Terrence Finn, a Director of Cibus, Inc., constitutes a related party transaction as it involves a transaction between the company and an insider.

Stakeholder Impact

• Shareholders: The grant of options can align the director's interests with shareholder value, potentially leading to better long-term performance. However, future exercise of options could lead to minor dilution.
• Employees: No direct impact mentioned for general employees.

Next Steps

• The options will vest on the earlier of May 22, 2026, or the date of the Company's next annual meeting of shareholders, subject to continued service.
• Upon vesting, Mark Terrence Finn will have the right to exercise these options and acquire Class A Common Stock.

Key Dates

Keywords

Cibus, CBUS, Form 4, Stock Options, Insider Transaction, Director Compensation, Beneficial Ownership, Equity Grant, SEC Filing